Staging and Treatment of Localized NSCLC

This chapter covers the staging of localized non-small cell lung cancer (NSCLC) using the TNM classification, emphasizing the importance of tumor characteristics and diagnostic procedures. It outlines treatment strategies for stages 1A to 3A, including surgical options and systemic therapies, while highlighting recent clinical trials that inform current protocols. The discussion also focuses on the integration of molecular testing and the role of multidisciplinary teams in optimizing patient outcomes through tailored therapies.